Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196)
China
· Delayed Price · Currency is CNY
27.40
+0.55 (2.05%)
Nov 20, 2024, 11:30 AM CST
Shanghai Fosun Pharmaceutical (Group) Revenue
Shanghai Fosun Pharmaceutical (Group) had revenue of 10.45B CNY in the quarter ending September 30, 2024, with 12.30% growth. This brings the company's revenue in the last twelve months to 41.61B, down -3.29% year-over-year. In the year 2023, Shanghai Fosun Pharmaceutical (Group) had annual revenue of 41.40B, down -5.81%.
Revenue (ttm)
41.61B
Revenue Growth
-3.29%
P/S Ratio
1.76
Revenue / Employee
1.03M
Employees
40,370
Market Cap
65.08B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 41.40B | -2.55B | -5.81% |
Dec 31, 2022 | 43.95B | 4.94B | 12.66% |
Dec 31, 2021 | 39.01B | 8.70B | 28.72% |
Dec 31, 2020 | 30.31B | 1.72B | 6.02% |
Dec 31, 2019 | 28.59B | 3.67B | 14.72% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionShanghai Fosun Pharmaceutical (Group) News
- 1 year ago - Generic drugmakers start shipping copies of Takeda's ADHD drug Vyvanse - Reuters
- 2 years ago - Fosun Pharma Shares Gain After Tie-Up With New Covid Drug Supplier Genuine Biotech - Forbes
- 2 years ago - Week In Review: Nuance In-Licenses RSV Vaccine In $225 Million Deal - Seeking Alpha
- 3 years ago - Pandemic Accelerates China's Drive Into mRNA Treatments - Seeking Alpha
- 3 years ago - Week In Review: Genscript And Its Legend Bio Subsidiary Raise $1 Billion From Hillhouse - Seeking Alpha
- 3 years ago - Week In Review: CANbridge Licenses LogicBio's Adeno-Associated Virus For Gene Therapies In $591 Million Deal - Seeking Alpha
- 3 years ago - Fosun Pharma shares tumble more than 5% as Hong Kong suspends BioNTech Covid vaccinations - CNBC